Back to search

Article

Aspirin and Cancer: An Updated Minireview

2026-06-30

Abstract excerpt

Aspirin (acetylsalicylic acid), synthesized by Bayer chemist Felix Hoffmann in 1897, remains one of the most extensively studied repurposed drugs in oncology. It is a component of the World Health Organization’s List of Essential Medicines due to its safety, efficacy, and affordability. Decades of epidemiological data, long-term follow-up of cardiovascular prevention trials, and dedicated chemoprevention studies...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
e87ee21f-f6b8-5598-9a58-6b460125baba
DOI
10.32388/xribgm
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
Aspirin and Cancer: An Updated MinireviewDOI 10.32388/xribgm
The Association Between Colorectal Cancer and Pharmaceuticals with Emphasis on Low-Dose Aspirin and AnticoagulantsSemantic proximity
The Protective Effects of Aspirin Use from Adverse In Hospital Outcomes and Metastatic Disease in Colorectal Cancer: An Evaluation of the National Inpatient SampleSemantic proximity
Aspirin and Cancer Survival: An Analysis of Molecular MechanismsSemantic proximity
Salicylic acid and risk of colorectal cancer: a two sample Mendelian randomization studySemantic proximity
Shielding Effects of Aspirin Use from Adverse in Hospital Outcomes in Non-Metastatic Pancreatic Cancer: An Evaluation of the National Inpatient SampleSemantic proximity
Aspirin therapy for colorectal cancer with PIK3CA mutation: simply complex!Semantic proximity
Aspirin and cancer survival-related pathways: a review and analysis of molecular mechanismsSemantic proximity
Adjuvant aspirin for colorectal cancer with PIK3CA-mutated and COX-2 overexpressed tumours: the ASCOLT translational research study and meta-analysis.Semantic proximity
Aspirin exerts high anti-cancer activity in PIK3CA-mutant colon cancer cellsSemantic proximity
Aspirin, the new targeted therapy in colorectal cancer.Semantic proximity
Aspirin use, tumor PIK3CA mutation, and colorectal-cancer survival.Semantic proximity
Aspirin use and risk of colorectal cancer according to BRAF mutation status.Semantic proximity
Select a neighboring publication to make it the new centre.